Dogwood Therapeutics, Inc.·4

Jul 1, 2:11 PM ET

Gendreau Roger Michael 4

4 · Dogwood Therapeutics, Inc. · Filed Jul 1, 2025

Insider Transaction Report

Form 4
Period: 2025-06-27
Gendreau Roger Michael
CHIEF MEDICAL OFFICER
Transactions
  • Award

    Stock Option (right to buy)

    2025-06-27+12,07512,075 total
    Exercise: $4.71Exp: 2035-06-27Common Stock (12,075 underlying)
Footnotes (1)
  • [F1]The stock option vests one-third on June 27, 2026 and 1/24th monthly thereafter.

Documents

1 file
  • 4
    form4-07012025_060708.xmlPrimary